Latest Avoro Capital Advisors LLC Stock Portfolio
$8.57Billion– No. of Holdings #46
Avoro Capital Advisors LLC Performance:
2024 Q1: 8.32%YTD: 8.32%2023: 7.6%
Performance for 2024 Q1 is 8.32%, and YTD is 8.32%, and 2023 is 7.6%.
About Avoro Capital Advisors LLC and 13F Hedge Fund Stock Holdings
Avoro Capital Advisors LLC is a hedge fund based in NEW YORK, NY. On 10-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $7.8 Billions. In it's latest 13F Holdings report, Avoro Capital Advisors LLC reported an equity portfolio of $8.6 Billions as of 31 Mar, 2024.
The top stock holdings of Avoro Capital Advisors LLC are UTHR, APLS, ASND. The fund has invested 7.7% of it's portfolio in UNITED THERAPEUTICS CORP and 7.6% of portfolio in APELLIS PHARMACEUTICALS INC.
The fund managers got completely rid off MIRATI THERAPEUTICS INC (MRTX), CYMABAY THERAPEUTICS INC (CBAY) and STRUCTURE THERAPEUTICS INC stocks. They significantly reduced their stock positions in ALNYLAM PHARMACEUTICALS INC (ALNY), SPDR SERIES TRUST - S&P BIOTECH (BIL) and KRYSTAL BIOTECH INC (KRYS). Avoro Capital Advisors LLC opened new stock positions in VIKING THERAPEUTICS INC (VKTX), ALPINE IMMUNE SCIENCES INC (ALPN) and VERA THERAPEUTICS INC (VERA). The fund showed a lot of confidence in some stocks as they added substantially to ARROWHEAD PHARMACEUTICALS INC (ARWR), TAYSHA GENE THERAPIES INC (TSHA) and TOURMALINE BIO INC.
The top stock holdings of Avoro Capital Advisors LLC are UTHR, APLS, ASND. The fund has invested 7.7% of it's portfolio in UNITED THERAPEUTICS CORP and 7.6% of portfolio in APELLIS PHARMACEUTICALS INC.
The fund managers got completely rid off MIRATI THERAPEUTICS INC (MRTX), CYMABAY THERAPEUTICS INC (CBAY) and STRUCTURE THERAPEUTICS INC stocks. They significantly reduced their stock positions in ALNYLAM PHARMACEUTICALS INC (ALNY), SPDR SERIES TRUST - S&P BIOTECH (BIL) and KRYSTAL BIOTECH INC (KRYS). Avoro Capital Advisors LLC opened new stock positions in VIKING THERAPEUTICS INC (VKTX), ALPINE IMMUNE SCIENCES INC (ALPN) and VERA THERAPEUTICS INC (VERA). The fund showed a lot of confidence in some stocks as they added substantially to ARROWHEAD PHARMACEUTICALS INC (ARWR), TAYSHA GENE THERAPIES INC (TSHA) and TOURMALINE BIO INC.
Avoro Capital Advisors LLC Equity Portfolio Value
Last Reported on: 15 May, 2024
Avoro Capital Advisors LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Avoro Capital Advisors LLC made a return of 8.32% in the last quarter. In trailing 12 months, it's portfolio return was 20.02%.
New Buys
| Ticker | $ Bought |
|---|---|
| viking therapeutics inc | 294,380,000 |
| alpine immune sciences inc | 228,921,000 |
| vera therapeutics inc | 227,027,000 |
| macrogenics inc | 90,528,000 |
| autolus therapeutics plc | 78,765,400 |
| ocular therapeutix inc | 65,055,300 |
| vaxcyte inc | 39,278,200 |
| cg oncology inc | 30,730,000 |
New stocks bought by Avoro Capital Advisors LLC
Additions
| Ticker | % Inc. |
|---|---|
| arrowhead pharmaceuticals inc | 657 |
| taysha gene therapies inc | 328 |
| tourmaline bio inc | 155 |
| ultragenyx pharmaceutical inc | 137 |
| avidity biosciences inc | 132 |
| soleno therapeutics inc | 107 |
| iovance biotherapeutics inc | 74.63 |
| marinus pharmaceuticals inc | 31.45 |
Additions to existing portfolio by Avoro Capital Advisors LLC
Reductions
| Ticker | % Reduced |
|---|---|
| alnylam pharmaceuticals inc | -73.00 |
| spdr series trust - s&p biotech | -3.25 |
| krystal biotech inc | -0.39 |
Avoro Capital Advisors LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| cymabay therapeutics inc | -262,444,000 |
| mirati therapeutics inc | -287,102,000 |
| structure therapeutics inc | -95,106,700 |
| fennec pharmaceuticals inc | -13,464,000 |
| immunogen inc | -25,943,800 |
| nuvalent inc | -13,166,800 |
| karuna therapeutics inc | -39,563,800 |
Avoro Capital Advisors LLC got rid off the above stocks
Sector Distribution
Avoro Capital Advisors LLC has about 80.6% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 80.6 |
| Others | 19.4 |
Market Cap. Distribution
Avoro Capital Advisors LLC has about 19.2% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 50.5 |
| UNALLOCATED | 19.4 |
| LARGE-CAP | 19.2 |
| SMALL-CAP | 8.9 |
| MICRO-CAP | 1.9 |
Stocks belong to which Index?
About 45.2% of the stocks held by Avoro Capital Advisors LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 54.8 |
| RUSSELL 2000 | 45.2 |
Avoro Capital Advisors LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Avoro Capital Advisors LLC
Avoro Capital Advisors LLC has 46 stocks in it's portfolio. About 58.9% of the portfolio is in top 10 stocks. FOLD proved to be the most loss making stock for the portfolio. VKTX was the most profitable stock for Avoro Capital Advisors LLC last quarter.
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AADI | aadi biosciences inc | 0.08 | 2,849,400 | 6,667,600 | unchanged | 0.00 | ||
| ADVM | adverum biotechnologies inc | 0.07 | 416,666 | 5,891,660 | new | |||
| AGLE | spyre therapeutics inc | 0.81 | 1,839,140 | 69,758,500 | unchanged | 0.00 | ||
| ALNY | alnylam pharmaceuticals inc | 0.52 | 300,000 | 44,835,000 | reduced | -73.00 | ||
| ALPN | alpine immune sciences inc | 2.67 | 5,775,000 | 228,921,000 | new | |||
| APLS | apellis pharmaceuticals inc | 7.62 | 11,111,100 | 653,111,000 | unchanged | 0.00 | ||
| ARGX | argenx se | 5.69 | 1,238,470 | 487,609,000 | added | 0.32 | ||
| ARWR | arrowhead pharmaceuticals inc | 2.85 | 8,555,560 | 244,689,000 | added | 657 | ||
| ASND | ascendis pharma | 6.99 | 3,966,670 | 599,641,000 | added | 5.62 | ||
| AUTL | autolus therapeutics plc | 0.92 | 12,345,700 | 78,765,400 | new | |||
| BCRX | biocryst pharmaceuticals inc | 0.77 | 13,050,000 | 66,294,000 | unchanged | 0.00 | ||
| BIL | spdr series trust - s&p biotech | 4.76 | 4,300,000 | 408,027,000 | reduced | -3.25 | ||
| BMRN | biomarin pharmaceutical inc | 4.45 | 4,365,000 | 381,239,000 | added | 1.51 | ||
| CBAY | cymabay therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CERE | cerevel therapeutics hldng | 3.72 | 7,555,560 | 319,373,000 | unchanged | 0.00 | ||
| CRSP | crispr therapeutics ag | 0.33 | 419,580 | 28,598,600 | new | |||
| FENC | fennec pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| FOLD | amicus therapeutics inc | 3.77 | 27,400,000 | 322,772,000 | unchanged | 0.00 | ||
| GLUE | monte rosa therapeutics inc | 0.37 | 4,535,000 | 31,971,800 | unchanged | 0.00 | ||
| IMGN | immunogen inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||